Study of IVIg vs. Placebo to Treat Subjects with Stiff-Person Syndrome (SPS) Spectrum Disorders
Rochester, MN
The purpose of this study is to assess in a blinded, randomized controlled fashion, whether 9 weeks of immunoglobulin therapy (IVIG) can reduce stiffness and spasms in subjects with Stiff-Person Syndrome (SPS).